Page last updated: 2024-08-21

diphenylamine and Juvenile Chronic Myelogenous Leukemia

diphenylamine has been researched along with Juvenile Chronic Myelogenous Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akutagawa, J; Braun, BS; Chang, T; Kogan, S; Krisman, K; Lauchle, JO; Shannon, K; Theobald, EH; Xu, J	1

Other Studies

1 other study(ies) available for diphenylamine and Juvenile Chronic Myelogenous Leukemia

Article	Year
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. The Journal of clinical investigation, 2013, Volume: 123, Issue:1 Topics: Animals; Benzamides; Cell Differentiation; Cell Proliferation; Child; Child, Preschool; Diphenylamine; Disease Models, Animal; Erythropoiesis; Hematopoiesis, Extramedullary; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Juvenile; Mice; Mice, Mutant Strains; Mitogen-Activated Protein Kinase Kinases; Neurofibromatosis 1; Neurofibromin 1	2013

Article

Year

Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.

The Journal of clinical investigation, 2013, Volume: 123, Issue:1

Topics: Animals; Benzamides; Cell Differentiation; Cell Proliferation; Child; Child, Preschool; Diphenylamine; Disease Models, Animal; Erythropoiesis; Hematopoiesis, Extramedullary; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Juvenile; Mice; Mice, Mutant Strains; Mitogen-Activated Protein Kinase Kinases; Neurofibromatosis 1; Neurofibromin 1

2013